FDA Enforcement Class II Ongoing

DxI 9000 Access Immunoassay Analyzer, REF C11137, Sofware Versions 1.15 and below; invitro diagnostic

Recall: Z-0107-2024 · Reported October 18, 2023

Enforcement

Recall Number
Z-0107-2024
Event ID
93023
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Beckman Coulter, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
October 18, 2023
Initiation Date
September 12, 2023
Classification Date
October 12, 2023
Address
1000 Lake Hazeltine Dr, N/A, Chaska, MN, 55318-1037, United States

Description

DxI 9000 Access Immunoassay Analyzer, REF C11137, Sofware Versions 1.15 and below; invitro diagnostic

Reason

The firm has investigated and confirmed that when DxI 9000 is connected to Laboratory Information System (LIS, host), the sample barcode presented may be ignored and replaced with a sample ID that was previously in the same rack and position. This will cause a delay of result to the sample currently presented to the system (Sample B) and may result in an erroneous test result for the prior sample (Sample A), which gets associated with the results of sample B.

Code Info

UDI/DI 15099590732103, All DxI 9000 Access Immunoassay Analyzer running software version 1.15 or prior

Distribution

Worldwide - US Nationwide distribution in the state of Florida, and the countries of Croatia, Czechia, France, Germany, Ireland, Italy, Netherlands, New Zealand, South Africa, Spain, Switzerland, United Kingdom of Great Britain and Northern Ireland.

Quantity

36 units